Veterinary Medicines

Baycox 2,5% 2,5 g / 100 ml Roztwór doustny

Authorised
  • Toltrazuril
Download as PDF

Product identification

Medicine name:
Baycox 2,5% 2,5 g / 100 ml Roztwór doustny
Active substance:
  • Toltrazuril
Target species:
  • Chicken (hen)
  • Turkey
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Toltrazuril
    2.50
    milligram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (hen)
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        16
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51B
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0360
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."